Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
27,773,716
-
Shares change
-
+932,130
-
Total reported value, excl. options
-
$488,823,497
-
Value change
-
+$18,248,950
-
Put/Call ratio
-
19.8%
-
Number of buys
-
59
-
Number of sells
-
-35
-
Price
-
$17.60
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2016
118 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q2 2016.
AERIE PHARMACEUTICALS INC - COM (AERI) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,773,716 shares
.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (3,711,695 shares), WELLINGTON MANAGEMENT GROUP LLP (3,209,396 shares), DEERFIELD MANAGEMENT CO (2,520,585 shares), Partner Fund Management, L.P. (2,341,640 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,100,000 shares), Foresite Capital Management III, LLC (1,345,313 shares), TPG Group Holdings (SBS) Advisors, Inc. (1,237,466 shares), VANGUARD GROUP INC (1,006,552 shares), Foresite Capital Management II, LLC (975,285 shares), and BlackRock Fund Advisors (971,896 shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.